High BRD4 Expression is an Independent Prognostic Factor in Endometrial Carcinoma
Publication
, Conference
Saglam, O; Cao, B; Wang, X; Toruner, G; Conejo-Garcia, J
Published in: LABORATORY INVESTIGATION
2021
Duke Scholars
Published In
LABORATORY INVESTIGATION
EISSN
1530-0307
ISSN
0023-6837
Publication Date
2021
Volume
101
Issue
SUPPL 1
Start / End Page
743 / 743
Related Subject Headings
- Pathology
- 3202 Clinical sciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Saglam, O., Cao, B., Wang, X., Toruner, G., & Conejo-Garcia, J. (2021). High BRD4 Expression is an Independent Prognostic Factor in Endometrial Carcinoma. In LABORATORY INVESTIGATION (Vol. 101, pp. 743–743).
Saglam, Ozlen, Biwei Cao, Xuefeng Wang, Gokce Toruner, and Jose Conejo-Garcia. “High BRD4 Expression is an Independent Prognostic Factor in Endometrial Carcinoma.” In LABORATORY INVESTIGATION, 101:743–743, 2021.
Saglam O, Cao B, Wang X, Toruner G, Conejo-Garcia J. High BRD4 Expression is an Independent Prognostic Factor in Endometrial Carcinoma. In: LABORATORY INVESTIGATION. 2021. p. 743–743.
Saglam, Ozlen, et al. “High BRD4 Expression is an Independent Prognostic Factor in Endometrial Carcinoma.” LABORATORY INVESTIGATION, vol. 101, no. SUPPL 1, 2021, pp. 743–743.
Saglam O, Cao B, Wang X, Toruner G, Conejo-Garcia J. High BRD4 Expression is an Independent Prognostic Factor in Endometrial Carcinoma. LABORATORY INVESTIGATION. 2021. p. 743–743.
Published In
LABORATORY INVESTIGATION
EISSN
1530-0307
ISSN
0023-6837
Publication Date
2021
Volume
101
Issue
SUPPL 1
Start / End Page
743 / 743
Related Subject Headings
- Pathology
- 3202 Clinical sciences
- 1103 Clinical Sciences